CTOs on the Move

MedicaMetrix

www.medicametrix.com

 
We are a startup up medical device company whose sole focus and mission are to transform patient care through innovative Med-tech solutions. Our initial product is a minimally invasive Prostate Volume Measurement Device to help doctors evaluate a patient`s prostate health. Our solution includes a controller that receives measurement data from an encoder device. The encoder a disposable, single-use component made with an injection molding process. We are in the proof of concept phase and want to move to test marketing trials and production by end of 2020.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Nanomix

Our Vision is to make healthcare accessible to patients, without compromise, by delivering the highest quality, fastest, cost effective and portable detection systems that bring the patient and caregiver closer together.

Emmer Development

Emmer Development Corp. is a Gainesville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biosearch Medical Products

Biosearch Medical Products is a Branchburg, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Miami Medical

Miami Medical is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Armetheon

Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.